Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Balazs Odler

Showing results (41-50 of 46) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 46 results.
Rheumatology International|July 8, 2025
Endothelial function and vascular events in patients with limited cutaneous systemic sclerosis (EFVELSS): a prospective observational studyPhilipp Jud, Philipp Douschan, Teresa Sassmann, et al.
Frontiers in Immunology|September 28, 2023
COVID-19 outcomes in patients with a history of immune-mediated glomerular diseasesPhilipp Gauckler, Jana S Kesenheimer, Duvuru Geetha, et al.
Autoimmunity Reviews|September 17, 2020
Rituximab in adult minimal change disease and focal segmental glomerulosclerosis - What is known and what is still unknown?Philipp Gauckler, Jae Il Shin, Federico Alberici, et al.
Kidney International Reports|April 29, 2021
Rituximab in Membranous NephropathyPhilipp Gauckler, Jae Il Shin, Federico Alberici, et al.
Journal of the American Society of Nephrology : JASN|October 21, 2024
Long-Term Outcomes of Rituximab-Treated Adult Patients with PodocytopathiesPhilipp Gauckler, Anna Matyjek, Seleni Kapsia, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|August 7, 2023
Sodium-glucose cotransporter 2 inhibition in primary and secondary glomerulonephritisFernando Caravaca-Fontán, Kate Stevens, Maite Padrón, et al.
Pageof 5

Showing results (41-50 of 46) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 46 results.
Rheumatology International|July 8, 2025
Endothelial function and vascular events in patients with limited cutaneous systemic sclerosis (EFVELSS): a prospective observational studyPhilipp Jud, Philipp Douschan, Teresa Sassmann, et al.
Frontiers in Immunology|September 28, 2023
COVID-19 outcomes in patients with a history of immune-mediated glomerular diseasesPhilipp Gauckler, Jana S Kesenheimer, Duvuru Geetha, et al.
Autoimmunity Reviews|September 17, 2020
Rituximab in adult minimal change disease and focal segmental glomerulosclerosis - What is known and what is still unknown?Philipp Gauckler, Jae Il Shin, Federico Alberici, et al.
Kidney International Reports|April 29, 2021
Rituximab in Membranous NephropathyPhilipp Gauckler, Jae Il Shin, Federico Alberici, et al.
Journal of the American Society of Nephrology : JASN|October 21, 2024
Long-Term Outcomes of Rituximab-Treated Adult Patients with PodocytopathiesPhilipp Gauckler, Anna Matyjek, Seleni Kapsia, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|August 7, 2023
Sodium-glucose cotransporter 2 inhibition in primary and secondary glomerulonephritisFernando Caravaca-Fontán, Kate Stevens, Maite Padrón, et al.
Pageof 5